We confirmed that KB1P transplanted tumors are refractory to checkpoint inhibitors, as neither anti–PD-1 nor anti–TIM-3 changed the rate of tumor initiation or tumor growth (Fig. S5, H and I). Here, PDCD1 is linked to neoplasm.